Access to new cancer drugs

Germany is faster than other countries & has a better treatment strategy – This is shown the latest data. In the past it has already been shown that Germany is very successful in treating cancer of all forms. Germany is one of the most expensive health systems that patients benefit from. Patients have access to … Fortsätt läsa Access to new cancer drugs

Rheumatoid arthritis and the risk of cancer in the treatment with Abatacept

A new post-marketing world observation study   GOALS Researchers wanted to investigate whether abatacept in patients with RA has an increased risk of reporting overall cancer and certain cancers such as breast, lung, lymphoma, melanoma and non-melanoma skin cancer compared to other biological DMARDs (bDMARDs). Clinical Trials NCT03980639 Abatacept and the Risk of Cancer: a … Fortsätt läsa Rheumatoid arthritis and the risk of cancer in the treatment with Abatacept

Patienter med reumatoid artrit (RA) ha en ökad risk att utveckla vissa cancerformer och infektioner som allmänna befolkningen

Malign och infektionsrisk vid patienter med reumatoid artrit som orsakar abatacept med andra biologiska läkemdel. Läs nytt studie Patienten mit rheumatoider Arthritis (RA) haben im Vergleich zur Allgemeinbevölkerung ein erhöhtes Risiko, bestimmte Krebsarten und Infektionen zu entwickeln. Dazu die neuste Studie